Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Rupert McShane

MD FRCPsych


Associate Professor

  • Consultant Psychiatrist

I am interested in treatment-resistant depression and dementia.  Clinically, I lead the Oxfordshire ECT and ketamine services and run a memory clinic.My main focus is developing policy and monitoring arrangements for rapidly acting antidepressants such as ketamine.  I led the international academic conference on Ketamine and Related Compounds for Psychiatric Disorders in March 2018.  I work on ways of optimizing the effects of ketamine and am local PI for trials of rapidly acting antidepressants.
Following an NIHR-funded case series exploring the use of repeated ketamine for resistant depression, we have now treated over 200 patients and are continuing to refine treatment protocols.  I led a qualitative study of ECT, which led to the creation of a Healthtalk module of patients talking about their experience and an exploration of why experiences are so polarised.As Coordinating Editor of the Cochrane Dementia and Cognitive Improvement Group, I have led programmes on reviews of diagnostic test accuracy, and modifiable risk factors for dementia.  I am currently exploring the use of telematics to help older people decide if they are still safe to drive.  I support NIHR funded and commercial dementia trials as local PI.


Key publications